Robotic Total Hip Arthroplasty Anesthesia Management

Study Overview
=================
Brief Summary
-----------------
Robotic arthroplasty is increasing in acceptance on a global scale as a result of advancements in orthopedic surgery technology. The investigators aimed to share their anesthesia management experience as well as compare robotic unilateral total hip arthroplasty with conventional surgical technique in this retrospective study.

Detailed Description
-----------------
This study was conducted after obtaining ethics committee approval. The inclusion criteria were as follows: American Society of Anesthesiologists (ASA) physical status I-III patients between 40-85 years, elective unilateral THAs which were performed by a single senior orthopedic surgeon and orthopedic team between January 2021 and January 2023 under CSEA. Exclusion criteria were urgent surgery, bilateral surgery, previous surgery, missing data, and lost to follow-up in the perioperative period. The routine anesthetic protocol for the TKA was as follows: A single dose of 0.5% hyperbaric bupivacaine between 15-10 mg was administered intratechally. Following this the epidural catheter was inserted 4 cm into the epidural space through the epidural needle and secured. The level of the sensory block was assessed using pin-prick and cold sensation tests, and motor block using the Bromage scale. The patients were followed in the postanesthesia care unit (PACU) after the surgery. Patients with a modified Aldrete scoring system ≥9 were considered to be eligible for the transfer from PACU to the service. Pain was evaluated using a Visual Analogue Scale (VAS) with regular intervals. Data were collected from hospital's electronic database records, patient files, and anesthesia charts.

Official Title
-----------------
Robotic Total Hip Arthroplasty Anesthesia Management: Retrospective Study

Conditions
-----------------
Hip Osteoarthritis, Joint Diseases, Anesthesia

Intervention / Treatment
-----------------
* Procedure: the robot assisted total hip arthroplasty
* Procedure: the conventional total hip arthroplasty


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: American Society of Anesthesiologists (ASA) physical status I-III Between 40-85 years Elective unilateral THAs which were performed by a single senior orthopedic surgeon Between January 2021 and January 2023 under CSEA. Exclusion Criteria: Urgent surgery Bilateral surgery Previous surgery Missing data and lost to follow-up in the perioperative period

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Group rTHA (robotic total hip arthroplasty)<br>the robot assisted total hip arthroplasty | Procedure: the robot assisted total hip arthroplasty<br>* the robot assisted total hip arthroplasty<br>|
| Group cTHA (conventional total hip arthroplasty)<br>the conventional total hip arthroplasty | Procedure: the conventional total hip arthroplasty<br>* the conventional total hip arthroplasty<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time | The duration of surgical procedures | Only in surgery time, an average of 3 hours] | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Complications | Perioperative complications rates | After the end of surgery, in the first 1-month follow-up | 
| Hospital discharge time | Time from the beginning of the operation to the discharge of hospital | Time from discharge from PACU to discharge from hospital, an average of 96 hours |